The U.S. Food and Drug Administration approved UPLIZNA (inebilizumab-cdon) for treating generalized myasthenia gravis in adults who test positive for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE